Shree Rama Multi-Tech Limited (**SRMTL**) is a prominent Indian manufacturer of primary packaging solutions, specializing in high-performance **Laminated Tubes**, **Tube Laminates**, and **Flexible Laminates**. As a subsidiary of **Nirma Chemical Works Private Limited (NCWPL)**, the company has undergone a significant financial and operational transformation, transitioning into a debt-free entity focused on high-growth segments within the **FMCG**, **Pharmaceutical**, and **Cosmetic** sectors. --- ### **Strategic Ownership and Corporate Structure** The company is backed by the **Nirma Group**, a major Indian conglomerate. Following a **₹63 crore** rights issue in **July 2023**, the promoter holding (Nirma Industries and Nirma Chemical Works) increased from **42.51%** to **61.57%**. As of March 31, 2024, **NCWPL** specifically holds a **56.53%** stake. * **Dematerialization:** **97.38%** of the paid-up equity share capital is held in dematerialized form. * **Subsidiary Status:** The company has one wholly-owned subsidiary, **Shree Rama (Mauritius) Limited**, which is currently **Defunct**. A full provision has been made for this investment (**₹13.06 lakhs**), and the company is seeking **RBI** approval to write it off under **FEMA** laws. * **Leadership:** **Shailesh K. Desai** serves as the Managing Director, recently re-appointed for a three-year term effective **August 3, 2024**. --- ### **Core Product Portfolio and Market Applications** SRMTL operates in a single reportable segment: **Manufacturing of Packaging Materials**. Its products are engineered to provide barriers against oxygen, moisture, light, and chemicals. * **Laminated Tubes ("Lami Tubes"):** The flagship product, used primarily for pastes and gels. Production volume grew by **8%** in the most recent fiscal year. * **Tube Laminates:** A high-growth sub-segment that recorded a **15.87%** production increase in 2023. * **Flexible Laminates:** Includes pouches and sachets tailored for the **FMCG** and food industries. * **Specialty Packaging:** Development of **Stand-up Pouches** with zips and high-quality graphics, designed to replace heavier metal cans and glass bottles. * **Multilayer Films:** Specialized films providing high-resistance barriers for sensitive pharmaceutical and cosmetic formulations. --- ### **Manufacturing Capabilities and Operational Footprint** The company has consolidated its operations to improve administrative and logistical efficiency. * **Primary Facility:** Located at **Moti-Bhoyan, Gandhinagar, Gujarat**. The registered office was moved to this site in 2023. * **Certifications:** The facility is **ISO 9001:2015**, **ISO 15378:2017 (GMP)**, and **DMF Type III** certified, ensuring compliance with global pharmaceutical standards. * **Asset Rationalization:** The company holds non-operational assets in **Pondicherry** (land and buildings valued at **₹247.35 lakhs**) classified as **assets held for sale**. --- ### **Revenue Distribution and Global Reach** While India remains the primary market, SRMTL maintains a diversified export footprint across four continents. **Geographical Revenue Breakdown (₹ in Lakhs)** | Region | FY 2023-24 | FY 2022-23 | | :--- | :--- | :--- | | **Within India** | **14,330.61** | **14,723.13** | | **Europe** | **1,571.81** | **1,469.73** | | **Africa** | **1,132.51** | **679.68** | | **Asia** | **603.16** | **2,510.36** | | **North America** | **60.19** | **89.54** | | **South West America** | **1.34** | **-** | | **Total Revenue** | **17,699.62** | **19,472.44** | --- ### **Growth Strategy: Capacity Expansion and Modernization** SRMTL is executing a capital expenditure (CAPEX) program to capture the projected **10-11% CAGR** in the laminated tube market through **2027**. * **Tubing Capacity:** Invested **~₹18 Crore** in new tubing machines (commissioned **April 2025**), increasing **Lamitube** capacity by **18-20%**. * **Technological Self-Reliance:** Invested **~₹17 Crore** in a **Multi-Layer Film Plant (MLFP)** with technology from **Reifenhauser, Germany** (commissioned **June 2024**). This reduces lead times and dependency on external job work. * **Sustainability & Cost Control:** Commissioned a **1.3 MW Solar Power Facility** in **July 2024** (**₹3.25 Crore**) to reduce energy costs and carbon footprint. * **Export Obligations:** Under the **EPCG Scheme**, the company has an export obligation of **₹226.51 Crore** over six years, following duty savings of **$540.18 lakhs** on imported machinery. --- ### **Financial Turnaround and Deleveraging** The **July 2023 Rights Issue** was a pivotal event that cleared the company's balance sheet of long-standing debt. * **Debt Repayment:** Utilized **₹61.72 crore** from the rights issue to repay term loans and redeem **Non-Convertible Debentures (NCDs)**. * **Interest Waiver:** Following the principal repayment, lenders waived accumulated interest and charges totaling **₹183.36 crore**. * **Profitability:** The company has maintained three years of consistent profits. **Net Profit (PAT)** rose to **₹9.96 crore** in FY 2023-24 from **₹5.04 crore** in FY 2022-23. * **Deferred Tax Assets:** Recognized **₹29.85 crore** in net deferred tax assets as of **March 2025**, signaling confidence in future taxable profits. * **Credit Ratings:** Previously rated **CRISIL BBB-/Stable** and **CRISIL A3**. Note: Ratings were withdrawn in **April 2024** at the company's request following the closure of the RBL Bank relationship. --- ### **Innovation and Sustainability Initiatives** To meet the demands of global brand owners and environmental regulations, SRMTL is investing in R&D for "Green Packaging." * **Eco-Friendly Materials:** Development of **Paper board-based tubes**, **Sugar cane paper tubes**, and **Post-Consumer Recycled (PCR)** tubes. * **Advanced Bioplastics:** Utilizing **Polybutylene succinate** and **Biopolypropylene** for puncture-resistant, low-impact packaging. * **Recyclability:** Active R&D focused on the separation of multi-layer laminates to facilitate easier recycling. --- ### **Risk Factors and Contingent Liabilities** Investors should note several ongoing legal and regulatory challenges. **1. Litigation and Tax Disputes:** * **Income Tax:** A major dispute involving **₹202.70 crore** regarding the disallowance of loan waiver gains (AY 12-13 & 13-14) is pending at the High Court/ITAT. * **Guarantees:** A **₹9.33 crore** guarantee for East West Polyart Ltd is pending at the **Debt Recovery Tribunal (DRT)**. * **Excise/GST:** Various disputes totaling approximately **₹3 crore** are in different stages of appeal. **2. Regulatory Hurdles:** * **Promoter Reclassification:** In **July 2025**, the **NSE** rejected the reclassification of **Stericon Pharma Private Limited** to "Public" due to its related-party status with the Nirma Group. * **Compliance Warnings:** The company received an **NSE warning** in **July 2025** for a **2-day delay** in material disclosures. * **Audit Qualifications:** Auditors continue to issue a **Qualified Opinion** because the accounts of the defunct Mauritius subsidiary have not been consolidated since **2005-06**. **3. Market and Operational Risks:** * **Raw Material Sensitivity:** Polymers and aluminum foils (crude oil derivatives) comprise **60-65%** of product value, making margins vulnerable to price volatility. * **Preference Share Obligations:** A petition is pending with the **NCLT** to issue **7,66,666** new preference shares to settle **₹6.67 crore** in unredeemed shares and **₹1 crore** in unpaid dividends.